Richmond Brothers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$267K |
| 2 |
APLT
Applied Therapeutics
APLT
|
+$204K |
| 3 |
IRD
Opus Genetics
IRD
|
+$105K |
| 4 |
Heron Therapeutics
HRTX
|
+$86.3K |
| 5 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
+$71.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.68M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$987K |
| 3 |
MiMedx Group
MDXG
|
+$783K |
| 4 |
Apple
AAPL
|
+$732K |
| 5 |
Microsoft
MSFT
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.03% |
| 2 | Healthcare | 26.15% |
| 3 | Technology | 14.18% |
| 4 | Financials | 10.16% |
| 5 | Consumer Discretionary | 1.56% |
Similar funds
Richmond Brothers's Q3 2023 Portfolio in Review
As of Q3 2023, Richmond Brothers held 25 positions worth $53.2M, down 14% from $61.8M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Richmond Brothers withdrew a net $5.8M in Q3 2023, closing 1 position and reducing 14 holdings. Its most notable exit was Invesco Global Listed Private Equity ETF, an estimated $556K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, down from 46% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Richmond Brothers opened a new position in Axonics, Inc. Common Stock worth $267K.
- Richmond Brothers's largest Q3 2023 buy was Axonics, Inc. Common Stock: 4,749 shares worth $267K.
- Richmond Brothers added most to Opus Genetics in Q3 2023, an estimated $105K increase.
- Richmond Brothers's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.68M.
- Richmond Brothers fully exited Invesco Global Listed Private Equity ETF in Q3 2023, selling an estimated $556K.
- Richmond Brothers's ten largest holdings make up 93% of its $53.2M portfolio in Q3 2023.
- Richmond Brothers opened 3 new positions and closed 1 in Q3 2023.
- Richmond Brothers's portfolio value fell 14% quarter-over-quarter to $53.2M.
Based on Richmond Brothers's 13F filing for Q3 2023, filed 3 Nov 2023.